Product
SIM0348
1 clinical trial
1 indication
Indication
CancerClinical trial
A Phase I, First-in-Human, Open-Label, Dose Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0348 in Subjects With Advanced Solid TumorsStatus: Not yet recruiting, Estimated PCD: 2024-12-30